Country for PR: United States
Contributor: PR Newswire New York
Saturday, January 30 2021 - 11:36
AsiaNet
DWHP Announces Expiration And Final Results Of Its Cash Tender Offer For All Outstanding Ordinary Shares Of Parnell Pharmaceuticals Holdings Ltd.
PARK CITY, Utah, Jan. 30, 2021 /PRNewswire-AsiaNet/--

DW Healthcare Partners V, L.P. ("DWHP"), announced today the expiration and 
final results of its previously announced cash tender offer (the "Tender 
Offer") to purchase all of the outstanding ordinary shares (the "Tender 
Securities") of Parnell Pharmaceuticals Holdings Ltd (OTC Pink Open Market: 
PARNF) ("Parnell") at a price of U.S.$0.40 per share, net to the seller in cash 
without interest and less applicable withholding taxes. The Tender Offer 
expired at one minute after 11:59 p.m., New York City time on January 28, 2021 
(the "Expiration Time"). 

Logo - https://mma.prnewswire.com/media/179742/dw_healthcare_partners_logo.jpg

The terms and conditions of the Tender Offer are described in the Offer to 
Purchase, dated December 21, 2020 ("Offer to Purchase") and related Letter of 
Transmittal (the "Letter of Transmittal").

The table below identifies the principal amount of the Tender Securities 
validly tendered and not validly withdrawn on or prior to the Expiration Time, 
and the principal amount of the Tender Securities that DWHP has accepted for 
purchase.

    Number of            Principal Amount of            Number of Tendered
    Tendered                  Tendered                      Securities
    Securities           Securities Tendered             Accepted by DWHP
  -------------------------------------------------------------------------
    6,241,664               $2,496,665.60                     6,241,664

DWHP previously announced the extension of the Tender Offer past one minute 
after 11:59 p.m. on January 21, 2021 (the "Original Expiration Time"). Taking 
into account Tender Securities validly tendered and not validly withdrawn prior 
to the Original Expiration Time, a total of $2,496,665.60, or 29%, of the 
aggregate outstanding ordinary shares of Parnell have been validly tendered and 
not validly withdrawn and accepted for purchase pursuant to the Tender Offer as 
of the Expiration Time. 

The cash consideration to be paid to holders of Tender Securities validly 
tendered after the Original Expiration Time and accepted for purchase in 
accordance with the terms of the Tender Offer will be $0.40 per Tendered 
Security net to the seller in cash without interest and less applicable 
withholding taxes. 

American Stock Transfer & Trust Company, LLC is acting as Depositary and Paying 
Agent in the Tender Offer. The Information Agent for the Tender Offer is D.F. 
King & Co., Inc.

Requests for documents and questions regarding the tender offer may be directed 
to DF King & Co. by telephone at (800) 399-1581 or banks and brokers may call 
(212) 269-5550. A copy of this press release can be found on Parnell's website 
at http://www.parnell.com.

The Tender Offer is being made pursuant to the Master Transaction Agreement, 
dated as of November 16, 2020 (together with any amendments or supplements 
thereto), between Parnell and DWHP, pursuant to which, after the completion of 
the Tender Offer and the satisfaction or waiver of certain conditions, DWHP 
will acquire a controlling interest in Parnell representing at least 50.01% of 
the ordinary shares outstanding. This press release is neither an offer to 
purchase nor a solicitation of an offer to sell securities, nor is it a 
substitute for the tender offer materials that DWHP has provided in connection 
with the tender offer. This communication is for informational purposes only. 

About DWHP

DW Healthcare Partners V, L.P. ("DWHP") is a limited partnership fund 
established in the Cayman Islands. DWHP is managed and operated by its general 
partner, DW Healthcare Management V, L.P., an exempted limited partnership 
formed in the Cayman Islands, which is managed by its general partner, DW 
Healthcare Management UGP V, LLC (a Delaware limited liability company).

SOURCE: DW Healthcare Partners V, L.P.

CONTACT: Eric Moore
         emoore@dwp.com